RxDoctor Payments DataLook up a doctor →

Charles Fogarty

Pulmonary Disease · Spartanburg, SCNPI 1316919194

Payments from drug & device makers

$18,724,351in general payments, 2019–2025

Across 7,986 payments — averaging $2344.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$6.7M
  • Modernatx, Inc.$5.9M
  • GSK$1.2M
  • Janssen Research & Development, LLC$1.1M
  • Emergent Biosolutions Inc.$844K
  • Novo Nordisk AS$524K
  • plus $2.5M from 39 others
$14,045in research payments, 2019–2025

Across 22 payments — averaging $638.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch Health US, LLC$9K
  • Sanofi$5K
  • GSK$923

What the payments were for

  • Travel & lodging$5,35153%
  • Food & beverage$4,62646%
  • Education$460%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca38$6,659,987
Modernatx, Inc.3,867$5,926,906
GSK226$1,155,654
Janssen Research & Development, LLC31$1,078,300
Emergent Biosolutions Inc.1,059$844,300
Novo Nordisk AS1,502$524,261
Johnson & Johnson19$355,030
Astrazeneca UK Limited10$278,340
Bausch Health US, LLC24$220,888
Astrazeneca AB4$215,459
Amphastar Pharmaceuticals, Inc.5$212,419
Pfizer31$196,689
Dermavant Sciences, Inc.783$196,244
Novavax Inc13$155,418
Genentech, Inc.24$116,186
Verona Pharma, Inc.6$107,977
Novartis5$87,883
Teva Pharmaceuticals USA, Inc.22$87,693
Cipla USA Inc.19$76,290
Sanofi9$65,533
Mylan Specialty L.p.9$40,286
Boehringer Ingelheim17$33,676
Amgen3$22,781
Roche Products Limited2$12,638
Boehringer Ingelheim International GmbH43$12,102
Sanofi US Services Inc.2$10,369
VYNE Pharmaceuticals Inc.2$9,345
Hexal AG23$8,540
Hoffmann-la Roche Limited1$6,450
Alnylam Pharmaceuticals Inc.89$3,622
Eli Lilly2$1,466
Electromed, Inc.60$807
Gilead12$271
Calyxo, Inc.2$167
Sunovion Pharmaceuticals Inc.6$92
Grifols USA, LLC3$55
Inspire Medical Systems, Inc.2$39
Resmed Corp3$37
Philips North America LLC2$37
Novo Nordisk1$32
Axsome Therapeutics, Inc.1$24
Actelion Pharmaceuticals US, Inc.1$20
Vapotherm Inc1$16
Mallinckrodt Enterprises LLC1$14
Genentech USA, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,724,351 in reported general payments places this provider in the 95th percentile of 192 pulmonary disease providers in South Carolina.

See all pulmonary disease providers in South Carolina →

Other pulmonary disease in Spartanburg

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →